amiodarone

(redirected from Nexterone)
Also found in: Dictionary, Thesaurus.

amiodarone

 [ah-me´o-dah-rōn″]
a potassium channel blocking agent used orally or by intravenous infusion as the hydrochloride salt in treatment of ventricular arrhythmias.

amiodarone

(ə-mē′ō-də-rōn′, -rən)
n.
A vasodilator drug, C25H29I2NO3, used in its hydrochloride form to control ventricular and supraventricular arrhythmias and to manage angina pectoris.

amiodarone

Cordorone® Cardiology A class III agent that prolongs the duration of the action potential; amiodarone is used to treat refractory ventricular and supraventricular tachycardia, A Fib, conduction block Adverse effects Pulmonary fibrosis, which occurs in ±6% of Pts taking the drug, hypothyroidism, hyperthyroidism, deposits in cornea—causing photosensitivity and/or skin-blue/gray skin pigmentation, leukocytoclastic vasculitis, hepatitis, ↑ digitoxin levels, neurotoxicity, GI toxicity

amiodarone

A drug used to treat heart rhythm irregularities such as paroxysmal ATRIAL FIBRILLATION. There are numerous side effects. A brand name is Cordarone X.
References in periodicals archive ?
"Nexterone is a great addition to our leading portfolio of premix drugs and solutions for the acute care setting.
"The development and approval of Nexterone has been Prism's greatest achievement," said Warren Cooper, chief executive officer of Prism Pharmaceuticals.
Prism was a specialty pharmaceutical company that developed the antiarrhythmic agent Nexterone, and was ultimately acquired by Baxter International in 2011 for USD 338m.